CorMedix Inc. Announces Commercial Agreement With
Post# of 103
![](/assets/46931549/no_avatar_available_thumb.jpg)
NEWS PROVIDED BY
CorMedix, Inc.
May 28, 2024, 8:30 AM ET
BERKELEY HEIGHTS, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a multi-year commercial supply contract with a top tier midsized dialysis provider for the supply of DefenCath® (taurolidine and heparin).
https://www.yourcentralvalley.com/business/pr...-provider/
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)